Physician profile
Bettaiah Gowda
NPI 1962491225
$897.74
in general payments reported to CMS, 2019-2025
17 companies · $37.17 in 2025
The $37.17 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.21 · 2020: $43.93 · 2021: $51.16 · 2022: $262 · 2023: $263 · 2024: $182 · 2025: $37.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $116.60 | 2019-2025 | |
| Celgene Corporation | $101.02 | 2023-2024 | Zeposia |
| Abbvie INC. | $91.22 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $90.58 | 2023 | Dupixent |
| Conmed Corporation | $77.15 | 2022 | |
| Janssen Biotech, INC. | $73.65 | 2022 | |
| Merck Sharp & Dohme LLC | $68.26 | 2021-2024 | Dificid |
| Mauna Kea Technologies, INC. | $53.24 | 2024 | |
| Intercept Pharmaceuticals, INC. | $47.08 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.74 | 2020-2022 | |
| Pfizer INC. | $37.18 | 2019-2021 | |
| Ethicon US, LLC | $20.61 | 2024 | Linx Reflux Management System |
| Aimmune Therapeutics, INC. | $17.00 | 2025 | Zenpep |
| Genzyme Corporation | $16.41 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.24 | 2023 | Linzess |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15.13 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bettaiah Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.